Company Monitoring Page for Bayer

latest headlines for company on cafepharma

Takeda's Baxalta settles with Bayer over $173M hemophilia patent infringement verdict
Fierce Pharma
Wed, 05/19/21 - 11:05 pm
Tags:
Baxalta, Takeda, hemophilia, patents, Bayer, Adynovate
Bayer sees jump in Essure adverse event reports gleaned from social media
Medtech Dive
Wed, 05/19/21 - 10:55 am
Tags:
Bayer, devices, Essure, contraceptives, social media, adverse events
Bayer (BAYRY) Inks Deal to Develop Therapies for Eye Diseases
Yahoo/Zacks.com
Tue, 05/18/21 - 11:15 pm
Tags:
Bayer, BlueRock Therapeutics, Fujifilm Cellular Dynamics, Opsis Therapeutics, cell therapy, eye diseases
ACC 2021: J&J, Bayer pad case for Xarelto in post-surgery artery disease patients
Fierce Pharma
Sun, 05/16/21 - 11:32 pm
Tags:
Bayer, JNJ, ACC, Xarelto, bloodthinners
Bayer's near-approval Farxiga rival meets goal in 2nd phase 3
Fierce Biotech
Mon, 05/10/21 - 10:03 am
Tags:
Bayer, finerenone, Farxiga, clinical trials, cardiovascular disease, myocardial infarction
Bay­er plots a ma­jor facelift at Berke­ley cam­pus, un­cork­ing a 30-year, $1.2B plan to dri­ve cell and gene ther­a­pies
Endpoints
Thu, 04/22/21 - 11:29 pm
Tags:
Bayer, Berkeley, cell therapy, gene therapy
Speak up, docs: Bayer's 'AMI' voice assistant talks prescription drug info for physicians
Fierce Pharma
Sun, 04/18/21 - 11:40 pm
Tags:
Bayer, physicians, pharma marketing, artificial intelligence
AACR: In redemption of the PI3K drug class, Bayer's Aliqopa leaps ahead of Gilead's Zydelig in lymphoma
Fierce Pharma
Sun, 04/11/21 - 11:36 pm
Tags:
AACR, Bayer, Aliqopa, non-Hodgkin lymphoma, follicular lymphoma, Zydelig
Bayer-backed Metagenomi bumps up series A to $75M as it gears up for gene editing push
Fierce Biotech
Wed, 04/7/21 - 10:37 am
Tags:
Metagenomi, Bayer, funding, venture capital
Bayer unveils first look at its post-Xarelto, post-Eylea life—and it's better than expected
Fierce Pharma
Wed, 03/10/21 - 10:49 pm
Tags:
Bayer, Xarelto, Eylea, patents, Stivarga, Verquvo
Clarivate Drugs to Watch Report Highlights Four Likely Blockbusters Among Drugs Launching in 2021
PR Newswire
Tue, 03/9/21 - 10:45 am
Tags:
Clarivate, Biogen, Eisai, aducanumab, UCB Pharma, bimekizumab, Relugolix, Pfizer, Takeda, Myovant, vericiguat, Bayer, Merck
Bayer’s gene therapy juggling act
EP Vantage
Mon, 02/8/21 - 10:35 am
Tags:
Bayer, gene therapy, AskBio
Pharma Rivals Step Up to Assist with COVID-19 Vaccine Production
Xtalks
Fri, 02/5/21 - 10:48 am
Tags:
vaccines, COVID-19, drug manufacturing, Bayer, GSK, Sanofi, CureVac
Bayer agrees to help CureVac produce coronavirus vaccine
BioPharma Dive
Mon, 02/1/21 - 11:06 pm
Tags:
Bayer, CureVac, COVID-19, vaccines
Leaps by Bayer backs a protein engineering startup taking on Aimmune — and Nestlé — in peanut allergy
Endpoints
Wed, 01/27/21 - 11:29 am
Tags:
Bayer, Aimmune, peanut allergy, Ukko, Nestle
How 2 scientific pioneers teamed up to run AskBio, Bayer's new gene therapy division
BioPharma Dive
Thu, 01/21/21 - 11:39 pm
Tags:
Bayer, AskBio, M&A, gene therapy
Can Merck and Bayer's newly approved Verquvo stand out in an ever-more-competitive heart failure field?
Fierce Pharma
Wed, 01/20/21 - 10:43 am
Tags:
Merck, Bayer, FDA, Verquvo, vericiguat, chronic heart failure
The top 10 largest biopharma M&A deals in 2020
Fierce Pharma
Tue, 01/19/21 - 10:30 am
Tags:
M&A, AstraZeneca, Alexion, Bristol-Myers Squibb, MyoKardia, Gilead Sciences, Forty Seven, Merck, VelosBio, Nestle, Aimmune, Immunomedics, JNJ, Momenta Pharmaceuticals, Sanofi, Principia Biopharma, Bayer, Asklepios BioPharmaeutical
Bayer pharma chief admits to unfillable revenue gap despite potential blockbuster launches
Fierce Pharma
Mon, 01/18/21 - 01:26 pm
Tags:
Bayer, Eylea, Xalreto
JPM: CureVac's new pharma partner Bayer says its COVID-19 vaccine not just an also-ran
Fierce Biotech
Wed, 01/13/21 - 10:53 am
Tags:
CureVac, Bayer, vaccines, COVID-19, JPMHC 2021

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.